Skip to main content
Premium Trial:

Request an Annual Quote

Tempus xT Cancer Genome Sequencing Panel

Tempus has introduced Tempus xT, a genome sequencing panel that analyzes 595 genes related to diagnosis, prognosis, and therapeutic targeting of cancer. Among other things, the panel looks for single-nucleotide variants, small insertions and deletions, amplifications of copy numbers, and structural alterations that could cause fusions, the company said. Chicago-based Tempus will run the xT panel at its own next-generation sequencing lab.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.